Results 171 to 180 of about 2,176,861 (324)

Randomized controlled study of nemolizumab in patients with chronic kidney disease-associated pruritus: NIKAIA-1 [PDF]

open access: hybrid
Vandana S. Mathur   +10 more
openalex   +1 more source

Elevated lymphoma risk in patients with chronic pruritus and chronic prurigo. [PDF]

open access: yesJ Dtsch Dermatol Ges
Royeck S   +10 more
europepmc   +1 more source

Analysis of C4 Concentrations to Predict Impact of Patient‐Reported Diarrhea Associated With the Ileal Bile Acid Transporter Inhibitor Linerixibat

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 596-605, March 2025.
ABSTRACT Linerixibat, an ileal bile acid transporter (IBAT) inhibitor, is being evaluated for the treatment of pruritus in primary biliary cholangitis (PBC). Diarrhea is commonly reported with this drug class as IBAT inhibition redirects bile acids (BA) to the colon.
Fernando Carreño   +4 more
wiley   +1 more source

High burden and suboptimal management of uremic pruritus among chronic kidney disease patients in Sennar state, Sudan: A cross-sectional study [PDF]

open access: bronze
Abdulrahman Abdullahi Ishag   +4 more
openalex   +1 more source

The polysaccharide Pullulan improves the initial steps of allergen‐specific immunotherapy in dogs

open access: yesVeterinary Record, EarlyView.
Abstract Background Allergen‐specific immunotherapy (AIT) is the only aetiological treatment for canine atopic dermatitis (CAD). Pullulan, a polysaccharide with immunomodulatory properties, may enhance AIT outcomes when combined with allergens such as recombinant Dermatophagoides farinae 2 (Der f 2).
Franco Martini   +3 more
wiley   +1 more source

Chronic Kidney Disease–Associated Pruritus in Danish Dialysis Patients: A Cross-Sectional Multicenter Study of Prevalence, Disease Burden, and Current Treatment Practices [PDF]

open access: gold
Gustav Østerlund Larsen   +9 more
openalex   +1 more source

Primary Biliary Cholangitis Unmasked in Metabolic Dysfunction‐Associated Steatohepatitis: When a Correct Diagnosis Is Incomplete

open access: yes
The Kaohsiung Journal of Medical Sciences, EarlyView.
Yucheng Cheng   +3 more
wiley   +1 more source

Real‐World Effectiveness, Treatment Course, and Safety of Tapinarof Cream 1% for Atopic Dermatitis and Plaque Psoriasis in Japan

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Background Tapinarof cream 1%, a non‐steroidal topical aryl hydrocarbon receptor‐modulating agent, is approved in Japan for atopic dermatitis (AD) and plaque psoriasis. Real‐world data on longitudinal outcomes, treatment continuation, interruption and restart, and adverse‐event timing are limited. Methods This single‐center retrospective study
Kanade Iino   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy